Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790]
Biomed Pharmacother. 2020 Jun:126:110077.
doi: 10.1016/j.biopha.2020.110077.
Epub 2020 Mar 12.
1 The Second Clinical College, School of Medicine, Wuhan University, Wuhan, 430071, China; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430071, China; Women and Children's Hospital of Hubei Province, NO. 745 Wu LuoRoad, Hongshan District, Wuhan, Hubei Province, China.
2 Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430010, China.
3 Department of Women Health Care, Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Women and Children's Hospital of Hubei Province, NO. 745 Wuluo Road, Hongshan District, Wuhan, Hubei Province, China.
4 Medical Research Institute, Wuhan University, Wuhan, 430071, China.
5 Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: Caihongbing2105@gmail.com.